ARCHIVES

Chemoprevention Clinical Trial RFA Being Developed For January Concept Review, Along With “Bridge” RFA

This article is from The Cancer Letter archive.

Vol. 07 No. 48 | November 27, 1981

Download PDF Visit The Full Archive

Related Articles

GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL

July 26, 2013

FDA To Reorganize Oncology Office Into Four Divisions By Disease Type

August 6, 2010

DCE Board Delays Decision On New Collaborative Groups In Chemoprevention

November 30, 1984

BCDDP Follow Up To Cost $1.6 Million annually For Five Years Okayed; Limited To 59,000 Women

November 3, 1978

NCI Appropriations Still Hung Up

September 30, 1977

Clinical Research: Cooperative Groups Form Coalition to Advance Trials

November 14, 1997